molecular profiling
BostonGene, Little Warrior Foundation Partner to Develop Sarcoma-Specific Liquid Biopsy
Liquid biopsy tests will be designed to detect molecular alterations and fusions specific to sarcoma using cell-free DNA and RNA.
Synergy Oncology to Develop Tumor Profiling Test Using Sophia Genetics DDM Platform
Synergy will incorporate Sophia DDM to launch Totality, a tumor molecular profiling assay to help physicians match variants to therapies and clinical trials.
Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform
Caris and ConcertAI will combine their multiomic and multimodal databases and AI technology to create a unified platform for use in oncology and hematology.
Genomic Testing Cooperative Implementing AI, Molecular Profiling to Improve Cancer Diagnosis
Premium
In a recent paper, GTC and its partners validated their RNAnalysis and TraceWork algorithms for targeted transcriptome and clinical decision support.
BostonGene, Mass General Hospital Cancer Center Form Research Alliance
BostonGene will use its computational platform to find associations between tumor genetics, the immune system, and the effectiveness of new treatments.